Page last updated: 2024-11-10

7-nitrobenz-2-oxa-1,3-diazole-phallacidin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

7-nitrobenz-2-oxa-1,3-diazole-phallacidin: fluorescent probe for actin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID4682184
MeSH IDM0092540

Synonyms (11)

Synonym
nbd-phallicidin
nitrobenzoxadiazole-phallacidin
nbd-ph
7-nitrobenz-2-oxa-1,3-diazole-phallacidin
phallacidin, 5-(erythro-3-hydroxy-n-(2-((7-nitro-4-benzofurazanyl)amino)ethyl)-d-asparagine)-
73413-78-2
nbodp
n-(7-nitrobenzofurazan-4-yl)phallacidin
2-[28-(2,3-dihydroxy-2-methylpropyl)-18-hydroxy-23-methyl-15,21,24,26,29,32,35-heptaoxo-31-propan-2-yl-12-thia-10,16,22,25,27,30,33,36-octazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4,6,8-tetraen-34-yl]-2-hydroxy-n-[2-[(4-nitro-2,1,3-benz
CS-0534997
HY-D1525

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In measurements of cytosolic free calcium concentration ([Ca2+]i) by flow cytometry in Indo-1-loaded platelets, ADP's dose-response for actin polymerization was similar to that for calcium mobilization."( Heterogeneity in filamentous actin content among individual human blood platelets.
Cabral, C; Daley, JF; Kang, JH; Oda, A; Salzman, EW; Smith, M, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (63)

TimeframeStudies, This Drug (%)All Drugs %
pre-199040 (63.49)18.7374
1990's22 (34.92)18.2507
2000's1 (1.59)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other63 (98.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]